Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.54 |
| ▸ | CNR2 | P34972 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31545261 | 0.95 | CNR1 (0.57) | CNR1CNR2MEN1GAAKMT2A | |
| SCHEMBL11735384 | 0.88 | CNR1 (0.59) | CNR1CNR2MEN1GAAKMT2A | |
| SCHEMBL31545535 | 0.87 | CNR1 (0.61) | CNR1CNR2MEN1GAAKMT2A | |
| SCHEMBL29744991 | 0.83 | CNR2 (0.67) | CNR1CNR2MEN1GAAKMT2A | |
| SCHEMBL11737062 | 0.83 | CNR2 (0.67) | CNR1CNR2MEN1GAAKMT2A | |
| SCHEMBL31544898 | 0.79 | CNR1 (0.61) | CNR1CNR2MEN1GAAKMT2A | |
| SCHEMBL11737014 | 0.79 | CNR1 (0.61) | CNR1CNR2MEN1GAAKMT2A | |
| SCHEMBL11740314 | 0.78 | CNR1 (0.53) | CNR1CNR2MEN1GAAKMT2A | |
| SCHEMBL15995034 | 0.76 | CNR2 (0.50) | CNR1CNR2MEN1GAAKMT2A | |
| SCHEMBL9079211 | 0.75 | CNR2 (0.68) | CNR1CNR2MEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |